The estimated Net Worth of Douglas A Roeder is at least $90.1 Миллион dollars as of 30 August 2023. Mr. Roeder owns over 300,000 units of Tandem Diabetes Care Inc stock worth over $34,525,327 and over the last 11 years he sold TNDM stock worth over $55,382,552. In addition, he makes $215,966 as Independent Director at Tandem Diabetes Care Inc.
Sign up
Mr. Roeder TNDM stock SEC Form 4 insiders trading
Douglas has made over 15 trades of the Tandem Diabetes Care Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 300,000 units of TNDM stock worth $162,000 on 30 August 2023.
The largest trade he's ever made was selling 9,846,294 units of Tandem Diabetes Care Inc stock on 9 April 2021 worth over $22,154,162. On average, Douglas trades about 387,756 units every 71 days since 2013. As of 30 August 2023 he still owns at least 807,988 units of Tandem Diabetes Care Inc stock.
You can see the complete history of Mr. Roeder stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Douglas Roeder biography
Douglas A. Roeder serves as Independent Director of the Company. Mr. Roeder has served on our board of directors since May 2009. Mr. Roeder joined Delphi Ventures as an Associate in 1998, and has been a Partner since 2000, focusing on medical devices, diagnostics and biotechnology. Prior to joining Delphi Ventures, Mr. Roeder was an associate with Alex Brown’s Healthcare Investment Banking Group in San Francisco, where he focused on the medical device, life sciences and healthcare services industries. Mr. Roeder serves as a director of Senseonics Holdings, Inc. (NYSE-MKT: SENS), a continuous glucose monitoring company, and several privately held companies. He previously served as a director of Trivascular Technologies, Inc., a medical device company, which was acquired by Endologix, Inc. (NASDAQ: ELGX) in February 2016. He also previously worked with Putnam Associates, a strategy consulting firm focused on the pharmaceutical and biotechnology industries. Mr. Roeder holds an A.B. in Biochemistry from Dartmouth College.
What is the salary of Douglas Roeder?
As the Independent Director of Tandem Diabetes Care Inc, the total compensation of Douglas Roeder at Tandem Diabetes Care Inc is $215,966. There are 16 executives at Tandem Diabetes Care Inc getting paid more, with John Sheridan having the highest compensation of $10,560,900.
How old is Douglas Roeder?
Douglas Roeder is 49, he's been the Independent Director of Tandem Diabetes Care Inc since 2009. There are 16 older and 6 younger executives at Tandem Diabetes Care Inc. The oldest executive at Tandem Diabetes Care Inc is Dick Allen, 75, who is the Lead Independent Director.
What's Douglas Roeder's mailing address?
Douglas's mailing address filed with the SEC is C/O DELPHI VENTURES, 63 BOVET ROAD, SUITE 351, SAN MATEO, CA, 94402.
Insiders trading at Tandem Diabetes Care Inc
Over the last 11 years, insiders at Tandem Diabetes Care Inc have traded over $154,253,951 worth of Tandem Diabetes Care Inc stock and bought 4,118,443 units worth $11,618,906 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Douglas A Roeder и Nicole Vitullo. On average, Tandem Diabetes Care Inc executives and independent directors trade stock every 9 days with the average trade being worth of $885,878. The most recent stock trade was executed by Shannon Marie Hansen on 15 August 2024, trading 1,968 units of TNDM stock currently worth $84,093.
What does Tandem Diabetes Care Inc do?
tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan
What does Tandem Diabetes Care Inc's logo look like?
Complete history of Mr. Roeder stock trades at Tandem Diabetes Care Inc и Senseonics Inc
Tandem Diabetes Care Inc executives and stock owners
Tandem Diabetes Care Inc executives and other stock owners filed with the SEC include:
-
John Sheridan,
President, Chief Executive Officer, Director -
Kim Blickenstaff,
Chairman of the Board -
Brian Hansen,
Chief Commercial Officer, Executive Vice President -
Leigh Vosseller,
Chief Financial Officer, Executive Vice President, Treasurer -
David Berger,
Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary -
Susan Morrison,
Executive Vice President, Chief Administrative Officer -
Rebecca Robertson,
Independent Director -
John F. Sheridan,
Pres, CEO & Director -
David B. Berger Esq.,
Exec. VP & COO -
Elizabeth Anne Gasser,
Exec. VP & Chief Strategy Officer -
Brian B. Hansen,
Exec. VP & Chief Commercial Officer -
Leigh A. Vosseller,
Exec. VP, CFO & Treasurer -
David B. Berger,
Exec. VP, Chief Bus. Operations & Compliance Officer and Corp. Sec. -
Susan M. Morrison,
Exec. VP & Chief Admin. Officer -
Dick Allen,
Lead Independent Director -
Christopher Twomey,
Independent Director -
Douglas Roeder,
Independent Director -
Edward Cahill,
Independent Director -
Peyton Howell,
Independent Director -
Kathleen McGroddy-Goetz,
Independent Director -
Elizabeth Gasser,
Executive Vice President - Strategy and Corporate Development -
Shannon M. Hansen,
Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. -
Manuel Jaime,
Sr. VP of Technology & Digital Health -
Tom Fox,
Sr. VP of HR & Organizational Devel. -
Ross Sylvia,
VP of Marketing -
Rick Carpenter,
Chief Technical Officer -
Jim Leal,
Sr. VP of Operations -
Richard P. Valencia,
Director -
Jesse I Treu,
Director -
Howard E Jr Greene,
Director -
Fred E Cohen,
Director -
Lonnie M Smith,
Director -
Henry Anhalt,
Director -
John Cajigas,
CHIEF FINANCIAL OFFICER -
Management Partners Viii, L...,
-
Venture Partners Ii, L.P.Hl...,
-
Group Holdings (Sbs) Adviso...,
-
Parters Vii L P Domain,
10% owner -
Nicole Vitullo,
10% owner -
Kathleen K Schoemaker,
10% owner -
Brian K Halak,
10% owner -
Robert Anacone,
EXECUTIVE VP AND CCO -
Brian H Dovey,
10% owner -
James C Blair,
10% owner -
Vii Associates Lp Dp,
10% owner -
Jean Claude Kyrillos,
EVP & Chief Operating Officer -
Rajwant Sodhi,
Director -
James Leal,
Chief Manufacturing Officer -
Shannon Marie Hansen,
EVP & Chief Legal Officer -
Myoungil Cha,
Director -
Joao Paulo Falcao Malagueira,
Director -
Mark David Novara,
EVP & CHIEF COMMERCIAL OFFICER -
Rick Carpenter,
Chief Technology Officer